VAXIGRIP

This brand name is authorized in Brazil, Estonia, Israel, Lithuania, Singapore, South Africa, Tunisia.

Active ingredients

The drug VAXIGRIP contains one active pharmaceutical ingredient (API):

1
 
Read more about Influenza, inactivated, split virus

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group Classification
J07BB02 Influenza, purified antigen J Antiinfectives for systemic use → J07 Vaccines → J07B Viral vaccines → J07BB Influenza vaccines
Discover more medicines within J07BB02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
BR Câmara de Regulação do Mercado de Medicamentos 502821603157419, 502821604153417, 576720020055317, 576720020055417, 576720020055517
EE Ravimiamet 1115323, 1287907, 1287918, 1287929
IL מִשְׂרַד הַבְּרִיאוּת 1173
LT Valstybinė vaistų kontrolės tarnyba 1024943, 1026495, 1026496, 1026497, 1033589, 1033590, 1033591, 1033592
SG Health Sciences Authority 10545P
TN Direction de la Pharmacie et du Médicament 12063011
ZA Health Products Regulatory Authority T/30.1/674

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈